HIV-1 Tat: Coping with negative elongation factors

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 460-465

  Garber, Mitchell E ^a   Jones, Katherine A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ELONGATION FACTOR; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REVIEW; TRANSACTIVATION; VIRUS TRANSCRIPTION;

EID: 0033179335     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80077-6     Document Type: Article

References (40)

1. Hampsey M, Reinberg D: RNA polymerase II as a control panel for multiple coactivator complexes. Curr Opin Genet Dev 1999, 9:132-139.
2. Shilatifard A: The RNA polymerase II general elongation complex. Biol Chem 1998, 379:27-31.
3. Corden JL, Patturajan M: A CTD function linking transcription to splicing. Trends Biochem Sci 1997, 22:413-416.
4. Jones K: Taking a new TAK on Tat transactivation. Genes Dev 1997, 11:2593-2599.
5. Wada T, Takagi T, Yamaguchi Y, Ferdous A, Imai T, Hirose S, Sugimoto S, Yano K, Hartzog GA, Winston F et al.: DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev 1998, 12:343-356. This paper reports the identification of Spt4 and Spt5 (DSIF) as critical factors that regulate the DRB-sensitive step in transcription elongation. An accompanying paper [6•] presents genetic evidence that these factors also regulate elongation in vivo.
6. Hartzog G, Wada T, Handa H, Winston F: Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisae. Genes Dev 1998, 12:357-369. See annotation [5••].
7. Yamaguchi Y, Wada T, Watanabe D, Takagi T, Hasegawa J, Handa H: Structure and function of the human transcription elongation factor DSIF. J Biol Chem 1999, 274:8085-8092.
8. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, Hasegawa J, Handa H: NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 1999, 97:41-51. This paper describes the purification of a four-subunit, negative elongation factor complex that binds tightly to RNAPII and is critical for DRB-sensitive transcription. NELF is shown to act co-operatively with DSIF and the NELF-E subunit is identified as RD, a protein containing an RNA-recognition motif.
9. Wada T, Takagi T, Yamaguchi Y, Watanabe D, Handa H: Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J 1998, 17:7395-7403. This paper provides strong evidence that DSIF action directly counteracts P-TEFb.
10. Wu-Baer F, Lane W, Gaynor R: Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat transactivation. J Mol Biol 1998, 277:179-197. Identification of human Spt5 as a factor important for HIV-1 Tat trans-activation in vitro.
11. Zhu Y, Pe'ery T, Peng J, Ramathan Y, Marshall N, Marshall T, Amendt B, Mathews M, Price D: Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev 1997, 11:2622-2632.
12. Mancebo H, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Blau C, Hazuda D, Price D, Flores O: P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 1997, 11:2633-2644.
13. de Falco G, Giordano A: CDK9 (PITALRE): A multifunctional cdc2-related kinase. J Cell Physiol 1998, 177:501-506.
14. Peng J, Zhu Y, Milton J, Price D: Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 1998, 12:755-762.
15. Archambault J, Pan G, Cartier M, Marshall N, Zhang S, Dahmus M, Greenblatt J: FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO. J Biol Chem 1998, 273:27593-27601.
16. Cho H, Kim T-K, Mancebo H, Lane WS, Flores O, Reinberg D: A protein phosphatase functions to recycle RNA polymerase II. Genes Dev 1999, 13:1540-1552. This paper demonstrates that recombinant FCP1 is a CTD phosphatase specific for core RNAPII and can also act as a positive transcription elongation factor in a highly purified transcription system, alone or in the presence of TFIIF and TFIIS. Interestingly, the ability of FCP1 to act as an ELF does not require its CTD phosphatase activity.
17. Orphanides G, LeRoy G, Chang C, Luse DS, Reinberg D: FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 1998, 92:105-116. Identification of a novel two-subunit complex (FACT) that can enhance elongation on chromatin templates in vitro. FACT was shown subsequently to function in concert with a nucleosome-remodeling complex in vitro [18•].
18. LeRoy G, Orphanides G, Lane W, Reinberg D: Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science 1998, 282:1900-1904. See annotation [17••].
19. Otero G, Fellows J, Li Y, Dirac A, Gustafsson C, Erdjument-Bromage H, Tempst P, Svejstrup J: Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol Cell 1999, 3:109-118. Identification of a novel yeast complex ('elongator') that associates with the hyperphosphorylated form of RNAPII that is required for elongation in vivo and in vitro.
20. Gold M, Yang X, Herrmann C, Rice A: PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus tat transactivation in vivo. J Virol 1997, 72:4448-4453.
21. Wei P, Garber ME, Fang S-M, Fischer WH, Jones KA: A novel CDK9 associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462. Identification and cloning of Cyclin T (now called CycT1 ) as a protein associated with the HIV-1 Tat trans-activation domain and demonstration that Tat and CycT1 bind TAR RNA in a loop-sequence-specific manner.
22. Garber M, Wei P, Jones K: HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb complex to TAR RNA. Cold Spring Harb Symp Quant Biol 1998, 63:371-380.
23. Zhou Q, Chen D, Pierstorff E, Luo K: Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J 1998, 17:3681-3691.
24. Fujinaga L, Cujec T, Peng J, Garriga J, Price D, Grana X, Peterlin B: The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol 1998, 72:7154-7159.
25. Garber M, Wei P, Kewal-Ramani V, Mayall T, Herrmann C, Rice A, Littman D, Jones K: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998, 12:3512-3527. This paper demonstrates that Cys261 in the CycT1 TRM is necessary for binding to Tat and TAR RNA in vitro and that zinc is required for the protein-protein interaction. The murine CycT1 is shown to contain a tyrosine at position 261 and to be unable to support Tat Trans-activation in vivo; these defects are repaired by a point mutation that restores Cys261. Stable rodent cell lines expressing human CycT1 are shown to support transcription from an integrated HIV-1 provirus but to be unable to support virus replication. The defect in the mouse CycT1 protein was also reported elsewhere [26-28,31].
26. Bieniasz P, Grdina T, Bogerd H, Cullen B: Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J 1998, 17:7056-7065.
27. Chen D, Fong Y, Zhou Q: Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc Natl Acad Sci USA 1999, 96:2728-2733.
28. Fujinaga K, Taube R, Wimmer J, Cujec T, Peterlin B: Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci USA 1999, 96:1285-1290.
29. Wimmer J, Fujinaga K, Taube R, Cujec T, Zhu Y, Peng J, Price D, Peterlin B: Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology 1999, 255:182-189.
30. Ivanov D, Kwak Y, Nee E, Guo J, Garcia-Martinez L, Gaynor R: Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J Mol Biol 1999, 288:41-56.
31. Kwak Y, Ivanov D, Guo J, Nee E, Gaynor R: Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. J Mol Biol 1999, 288:57-69.
32. Ping Y, Rana T: Tat-associated kinase (P-TEFb): A component of transcription preinitiation and elongation complexes. J Biol Chem 1999, 274:7399-7404.
33. Chen D, Zhou Q: Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol Cell Biol 1999, 19:2863-2871.
34. Palangat M, Meier T, Keene R, Landick R: Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure. Mol Cell 1998, 1:1033-1042. Purified RNAPII is shown to pause at the HIV-1 promoter upon encountering an inhibitory RNA structure ('pause hairpin') that forms early in transcription and is disrupted by the subsequent formation of TAR RNA.
35. Marshall N, Dahmus G, Dahmus M: Regulation of carboxyl-terminal domain phosphatase by HIV-1 tat protein. J Biol Chem 1998, 273:31726-31730.
36. Herrmann C, Carroll R, Wei P, Jones K, Rice A: Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol 1998, 72:9881-9888.
37. Garriga J, Peng J, Parreno M, Price D, Henderson E, Grana X: Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene 1998, 17:3093-3102.
38. West M, Karn J: Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J 1999, 18:1378-1386.
39. Jiang YW, Veschambre P, Erdjument-Bromage H, Tempst P, Conaway JW, Conaway RC, Kornberg RD: Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci USA 1998, 95:8538-8543.
40. Landick R: Shifting RNA polymerase into overdrive. Science 1999, 284:598-599.